Cat. No. | Product name | CAS No. |
DCC3271 |
Mcl-1 Inhibitor-5
The first reversible covalent inhibitor for Mcl-1, a protein-protein interaction (PPI) target |
|
DCC3272 |
Mcl1-in-1
Novel potent and selective inhibitor of the apoptosis regulating proteins Mcl-1 |
713492-66-1 |
DCC3273 |
Mcmmad
Featured
Novel mc (maleimidocaproyl) linker plus MMAD (Monomethylauristatin D) to be used for prepare antibodies conjugates via cysteine-capped mechanism |
1401963-15-2 |
DCC3274 |
Mct4-in-18n
Novel highly selective inhibitor of monocarboxylate transporter 4 (MCT4/SLC16A3), resulting in lactate efflux inhibition and reduction of cellular viability in MCT4 high expressing cells |
|
DCC3275 |
Mcule-5948770040
Novel SARS-CoV-2 Main Protease (Mpro) inhibitor, binding to Subsites S1 and S2 (Kd=1.3 µM) |
|
DCC3276 |
Md-222
First-in-class highly potent PROTAC degrader of MDM2 |
2136246-72-3 |
DCC3277 |
Md-39-am
Diuretic agent, impling an increase in the Na+ excretion and showing antihypertensive effect |
72564-74-0 |
DCC3278 |
Mdc-1112
Novel valproic acid (VPA) derivative, as a potent STAT3 inhibitor |
|
DCC3279 |
Mdcccl1636
Novel partial PPARgamma ligand, displaying partial agonist activity in biochemical and cell-based transactivation assays, and reversed insulin resistance |
|
DCC3280 |
Mdctmp
Novel proteolysis-resistant self-localizing ligand (SL), sustaining PM localization of eDHFR-fusion proteins (over several hours to a day), inducing prolonged signal activation and cell differentiation |
|
DCC3281 |
Mde 6-82-1c
Novel MC5R antagonist |
|
DCC3282 |
Mde10-136rs
Novel potent and highly selective melanocortin-3 receptor (MC3R) agonist, showing greater than 140-fold selective for the mMC3R over the mMC4R, possessed 70 nM potency at the mMC3R, and partially stimulated the mMC4R at 100 μM concentrations without antag |
|
DCC3283 |
Mde6-5-2c
Novel potent and nonselective MC3R and MC4R macrocyclic agonist. decreased food intake and respiratory exchange ratio (RER) |
|
DCC3284 |
Mdg486
Novel Inhibitor of BAF, activating latent HIV-1 |
92071-89-1 |
DCC3285 |
mdg559
Novel peroxisome proliferator activated receptor |
512825-01-3 |
DCC3286 |
mdg582
Novel peroxisome proliferator activated receptor γ (PPARγ) ligand |
459197-34-3 |
DCC3287 |
Mdl100240
Dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase |
142695-08-7 |
DCC3288 |
Mdm2/x Pdi
Potent Peptide dual inhibitor of MDM2/X, inhibiting p53 interactions with MDM2 (IC50 = 10 nmol/L) and MDMX (IC50 = 100 nmol/L), inducing apoptosis and cell cycle arrest of cell lines with overexpressed MDM2/X |
|
DCC3289 |
Mdm2/xiap-in-14
Novel potent dual MDM2/XIAP inhibitor |
|
DCC3290 |
Mdm2-p53-in-1b
Novel inhibitor of the MDM2-p53 interaction |
856435-40-0 |
DCC3291 |
Mdmb-chminaca
Potent ligand of the central CB1 receptor |
1185888-32-7 |
DCC3292 |
Me1111
Novel selective inhibitor of succinate dehydrogenase (complex II) of dermatophyte species |
1391758-52-3 |